Close
Ira Longini

Professor

Education

Affiliations

Projects

Papers

Lee EC, Chao DL, Lemaitre JC, Matrajt L, Pasetto D, Perez-Saez J, Finger F, Rinaldo A, Sugimoto JD, Halloran ME, Longini IM Jr., Ternier R, Vissieres K, Azman AS, Lessler J, Ivers LC. (2020). Achieving coordinated national immunity and cholera elimination in Haiti through vaccination: a modelling study. The Lancet. Global health, 8(8)

Krause P, Fleming TR, Longini I, Henao-Restrepo AM, Peto R,. (2020). COVID-19 vaccine trials should seek worthwhile efficacy. Lancet

Zhang J, Litvinova M, Wang W, Wang Y, Deng X, Chen X, Li M, Zheng W, Yi L, Chen X, Wu Q, Liang Y, Wang X, Yang J, Sun K, Longini IM Jr., Halloran ME, Wu P, Cowling BJ, Merler S, Viboud C, Vespignani A, Ajelli M, Yu H. (2020). Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study. medRxiv : the preprint server for health sciences

Hladish TJ, Pearson CAB, Toh KB, Rojas DP, Manrique-Saide P, Vazquez-Prokopec GM, Halloran ME, Longini IM Jr.. (2020). Designing effective control of dengue with combined interventions. Proceedings of the National Academy of Sciences of the United States of America

Halloran ME, Longini IM, Gilbert PB. (2020). Designing a Study of Correlates of Risk for Ebola Vaccination. American journal of epidemiology

Aleta A, Martin-Corral D, Pastore Y Piontti A, Ajelli M, Litvinova M, Chinazzi M, Dean NE, Halloran ME, Longini IM, Merler S, Pentland A, Vespignani A, Moro E, Moreno Y. (2020). Modeling the impact of social distancing, testing, contact tracing and household quarantine on second-wave scenarios of the COVID-19 epidemic. medRxiv : the preprint server for health sciences

Jing QL, Liu MJ, Zhang ZB, Fang LQ, Yuan J, Zhang AR, Dean NE, Luo L, Ma MM, Longini I, Kenah E, Lu Y, Ma Y, Jalali N, Yang ZC, Yang Y. (2020). Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study. The Lancet. Infectious diseases

Dean NE, Halloran ME, Longini IM Jr.. (2020). Temporal Confounding in the Test Negative Design. American journal of epidemiology

Chinazzi M, Davis JT, Ajelli M, Gioannini C, Litvinova M, Merler S, Pastore Y Piontti A, Rossi L, Sun K, Viboud C, Xiong X, Yu H, Halloran ME, Longini IM Jr., Vespignani A. (2020). The effect of travel restrictions on the spread of the 2019 novel coronavirus (2019-nCoV) outbreak. medRxiv : the preprint server for health sciences

Aleta A, Martín-Corral D, Pastore Y Piontti A, Ajelli M, Litvinova M, Chinazzi M, Dean NE, Halloran ME, Longini IM Jr., Merler S, Pentland A, Vespignani A, Moro E, Moreno Y. (2020). Modelling the impact of testing, contact tracing and household quarantine on second waves of COVID-19. Nature human behaviour

Zhang J, Litvinova M, Wang W, Wang Y, Deng X, Chen X, Li M, Zheng W, Yi L, Chen X, Wu Q, Liang Y, Wang X, Yang J, Sun K, Longini IM Jr., Halloran ME, Wu P, Cowling BJ, Merler S, Viboud C, Vespignani A, Ajelli M, Yu H. (2020). Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study. The Lancet. Infectious diseases

Dean NE, Gsell PS, Brookmeyer R, Crawford FW, Donnelly CA, Ellenberg SS, Fleming TR, Halloran ME, Horby P, Jaki T, Krause PR, Longini IM, Mulangu S, Muyembe-Tamfum JJ, Nason MC, Smith PG, Wang R, Henao-Restrepo AM, De Gruttola V. (2020). Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks. The New England journal of medicine, 382(14)

Chinazzi Matteo, Davis Jessica T., Ajelli Marco, Gioannini Corrado, Litvinova Maria, Merler Stefano, Pastore y Piontti Ana, Mu Kunpeng, Rossi Luca, Sun Kaiyuan, Viboud Cécile, Xiong Xinyue, Yu Hongjie, Halloran M. Elizabeth, Longini Ira M., Vespignani Alessandro. (2020). The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science

Chinazzi Matteo, Davis Jessica T, Gioannini Corrado, Litvinova Maria, Pastore Y Piontti Ana, Rossi Luca, Xiong Xinyue, Halloran M Elizabeth, Longini Ira M, Vespignani Alessandro. (2020). Preliminary assessment of the International Spreading Risk Associated with the 2019 novel Coronavirus (2019-nCoV) outbreak in Wuhan City

Yang Yang, Lu Qingbin, Liu Mingjin, Wang Yixing, Zhang Anran, Jalali Neda, Dean Natalie, Longini Ira, Halloran M. Elizabeth, Xu Bo, Zhang Xiaoai, Wang Liping, Liu Wei, Fang Liqun. (2020). Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. Cold Spring Harbor Laboratory Press

Bellan SE, Eggo RM, Gsell PS, Kucharski AJ, Dean NE, Donohue R, Zook M, Edmunds WJ, Odhiambo F, Longini IM Jr., Brisson M, Mahon BE, Henao-Restrepo AM. (2019). An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool. Vaccine, 37(31)

Tsang TK, Ghebremariam SL, Gresh L, Gordon A, Halloran ME, Katzelnick LC, Rojas DP, Kuan G, Balmaseda A, Sugimoto J, Harris E, Longini IM Jr., Yang Y. (2019). Effects of infection history on dengue virus infection and pathogenicity. Nature communications, 10(1)

Dean NE, Gsell PS, Brookmeyer R, De Gruttola V, Donnelly CA, Halloran ME, Jasseh M, Nason M, Riveros X, Watson CH, Henao-Restrepo AM, Longini IM. (2019). Design of vaccine efficacy trials during public health emergencies. Science translational medicine, 11(499)

Tsang TK, Chen TM, Longini IM Jr., Halloran ME, Wu Y, Yang Y. (2018). Transmissibility of Norovirus in Urban Versus Rural Households in a Large Community Outbreak in China. Epidemiology (Cambridge, Mass.), 29(5)

Zarnitsyna VI, Bulusheva I, Handel A, Longini IM, Halloran ME, Antia R. (2018). Intermediate levels of vaccination coverage may minimize seasonal influenza outbreaks. PloS one, 13(6)

Pavía-Ruz N, Diana Patricia Rojas, Salha Villanueva, Granja P, Balam-May A, Longini IM, Halloran ME, Manrique-Saide P, Gómez-Dantés H. (2018). Seroprevalence of Dengue Antibodies in Three Urban Settings in Yucatan, Mexico. The American journal of tropical medicine and hygiene, 98(4)

Sun K, Zhang Q, Pastore-Piontti A, Chinazzi M, Mistry D, Dean NE, Rojas DP, Merler S, Poletti P, Rossi L, Halloran ME, Longini IM Jr., Vespignani A. (2018). Quantifying the risk of local Zika virus transmission in the contiguous US during the 2015-2016 ZIKV epidemic. BMC medicine, 16(1)

Longini IM, Røttingen JA, Kieny MP, Edmunds WJ, Henao-Restrepo AM. (2018). Questionable efficacy of the rVSV-ZEBOV Ebola vaccine - Authors' reply. Lancet, 391(10125)

Bisanzio D, Dzul-Manzanilla F, Gomez-Dantes H, Pavia-Ruz N, Hladish TJ, Lenhart A, Palacio-Vargas J, González Roldan JF, Correa-Morales F, Sánchez-Tejeda G, Kuri Morales P, Manrique-Saide P, Longini IM, Halloran ME, Vazquez-Prokopec GM. (2018). Spatio-temporal coherence of dengue, chikungunya and Zika outbreaks in Merida, Mexico. PLoS neglected tropical diseases, 12(3)

Hladish TJ, Pearson CAB, Patricia Rojas D, Gomez-Dantes H, Halloran ME, Vazquez-Prokopec GM, Longini IM. (2018). Forecasting the effectiveness of indoor residual spraying for reducing dengue burden. PLoS neglected tropical diseases, 12(6)

Rojas DP, Barrera-Fuentes GA, Pavia-Ruz N, Salgado-Rodriguez M, Che-Mendoza A, Manrique-Saide P, Vazquez-Prokopec GM, Halloran ME, Longini IM, Gomez-Dantes H. (2018). Epidemiology of dengue and other arboviruses in a cohort of school children and their families in Yucatan, Mexico: Baseline and first year follow-up. PLoS neglected tropical diseases, 12(11)

Dean NE, Halloran ME, Longini IM. (2018). Design of vaccine trials during outbreaks with and without a delayed vaccination comparator. The annals of applied statistics, 12(1)

Pavía-Ruz N, Barrera-Fuentes GA, Villanueva-Jorge S, Che-Mendoza A, Campuzano-Rincón JC, Manrique-Saide P, Rojas DP, Vazquez-Prokopec GM, Halloran ME, Longini IM, Gómez-Dantés H. (2018). Dengue seroprevalence in a cohort of schoolchildren and their siblings in Yucatan, Mexico (2015-2016). PLoS neglected tropical diseases, 12(11)

Halloran ME, Auranen K, Baird S, Basta NE, Bellan SE, Brookmeyer R, Cooper BS, DeGruttola V, Hughes JP, Lessler J, Lofgren ET, Longini IM, Onnela JP, Özler B, Seage GR, Smith TA, Vespignani A, Vynnycky E, Lipsitch M. (2017). Simulations for designing and interpreting intervention trials in infectious diseases. BMC medicine, 15(1)

Zhang Q, Sun K, Chinazzi M, Pastore Y Piontti A, Dean NE, Rojas DP, Merler S, Mistry D, Poletti P, Rossi L, Bray M, Halloran ME, Longini IM Jr., Vespignani A. (2017). Spread of Zika virus in the Americas. Proceedings of the National Academy of Sciences of the United States of America, 114(22)

Yang Y, Meng Y, Halloran ME, Longini IM Jr.. (2018). Dependency of Vaccine Efficacy on Preexposure and Age: A Closer Look at a Tetravalent Dengue Vaccine. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 66(2)

Yang Y, Meng Y, Halloran ME, Longini IM Jr.. (2018). Reply to Aguiar and Stollenwerk. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 66(4)

Kirpich A, Weppelmann TA, Yang Y, Morris JG Jr., Longini IM Jr.. (2017). Controlling cholera in the Ouest Department of Haiti using oral vaccines. PLoS neglected tropical diseases, 11(4)

Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Gsell PS, Hossmann S, Watle SV, Kondé MK, Kéïta S, Kone S, Kuisma E, Levine MM, Mandal S, Mauget T, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Røttingen JA, Kieny MP. (2017). Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet, 389(10068)

Rojas DP, Dean NE, Yang Y, Kenah E, Quintero J, Tomasi S, Ramirez EL, Kelly Y, Castro C, Carrasquilla G, Halloran ME, Longini IM. (2016). The epidemiology and transmissibility of Zika virus in Girardot and San Andres island, Colombia, September 2015 to January 2016. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 21(28)

Feldstein LR, Matrajt L, Elizabeth Halloran M, Keitel WA, Longini IM Jr., . (2016). Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies. Vaccine, 34(33)

Ajelli M, Merler S, Fumanelli L, Pastore Y Piontti A, Dean NE, Longini IM Jr., Halloran ME, Vespignani A. (2016). Spatiotemporal dynamics of the Ebola epidemic in Guinea and implications for vaccination and disease elimination: a computational modeling analysis. BMC medicine, 14(1)

Dean NE, Halloran ME, Yang Y, Longini IM. (2016). Transmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic Infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 62(10)

Fang LQ, Yang Y, Jiang JF, Yao HW, Kargbo D, Li XL, Jiang BG, Kargbo B, Tong YG, Wang YW, Liu K, Kamara A, Dafae F, Kanu A, Jiang RR, Sun Y, Sun RX, Chen WJ, Ma MJ, Dean NE, Thomas H, Longini IM Jr., Halloran ME, Cao WC. (2016). Transmission dynamics of Ebola virus disease and intervention effectiveness in Sierra Leone. Proceedings of the National Academy of Sciences of the United States of America, 113(16)

Flasche S, Jit M, Rodríguez-Barraquer I, Coudeville L, Recker M, Koelle K, Milne G, Hladish TJ, Perkins TA, Cummings DA, Dorigatti I, Laydon DJ, España G, Kelso J, Longini I, Lourenco J, Pearson CA, Reiner RC, Mier-Y-Terán-Romero L, Vannice K, Ferguson N. (2016). The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study. PLoS medicine, 13(11)

Hladish TJ, Pearson CA, Chao DL, Rojas DP, Recchia GL, Gómez-Dantés H, Halloran ME, Pulliam JR, Longini IM. (2016). Projected Impact of Dengue Vaccination in Yucatán, Mexico. PLoS neglected tropical diseases, 10(5)

Koepke AA, Longini IM Jr., Halloran ME, Wakefield J, Minin VN. (2016). PREDICTIVE MODELING OF CHOLERA OUTBREAKS IN BANGLADESH. The annals of applied statistics, 10(2)

Kenah E, Britton T, Halloran ME, Longini IM Jr.. (2016). Molecular Infectious Disease Epidemiology: Survival Analysis and Algorithms Linking Phylogenies to Transmission Trees. PLoS computational biology, 12(4)

Kirpich A, Weppelmann TA, Yang Y, Ali A, Morris JG Jr., Longini IM. (2016). Correction: Cholera Transmission in Ouest Department of Haiti: Dynamic Modeling and the Future of the Epidemic. PLoS neglected tropical diseases, 10(1)

Merler S, Ajelli M, Fumanelli L, Parlamento S, Pastore Y Piontti A, Dean NE, Putoto G, Carraro D, Longini IM Jr., Halloran ME, Vespignani A. (2016). Containing Ebola at the Source with Ring Vaccination. PLoS neglected tropical diseases, 10(11)

Kirpich A, Weppelmann TA, Yang Y, Ali A, Morris JG Jr., Longini IM. (2015). Cholera Transmission in Ouest Department of Haiti: Dynamic Modeling and the Future of the Epidemic. PLoS neglected tropical diseases, 9(10)

Schwartz LM, Halloran ME, Durbin AP, Longini IM Jr.. (2015). The dengue vaccine pipeline: Implications for the future of dengue control. Vaccine, 33(29)

Longini IM, Egger M, Dean NE, Edmunds WJ, Henao-Restrepo AM, . (2015). Ebola vaccination - Authors' reply. Lancet, 386(10012)

Merler S, Ajelli M, Fumanelli L, Gomes MF, Piontti AP, Rossi L, Chao DL, Longini IM Jr., Halloran ME, Vespignani A. (2015). Spatiotemporal spread of the 2014 outbreak of Ebola virus disease in Liberia and the effectiveness of non-pharmaceutical interventions: a computational modelling analysis. The Lancet. Infectious diseases, 15(2)

Yang Y, Zhang Y, Fang L, Halloran ME, Ma M, Liang S, Kenah E, Britton T, Chen E, Hu J, Tang F, Cao W, Feng Z, Longini IM Jr.. (2015). Household transmissibility of avian influenza A (H7N9) virus, China, February to May 2013 and October 2013 to March 2014. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 20(10)

Lipsitch M, Eyal N, Halloran ME, Hernán MA, Longini IM, Perencevich EN, Grais RF. (2015). Vaccine testing. Ebola and beyond. Science (New York, N.Y.), 348(6230)

Matrajt L, Britton T, Halloran ME, Longini IM Jr.. (2015). One versus two doses: What is the best use of vaccine in an influenza pandemic?. Epidemics, (13)

Halloran ME, Vespignani A, Bharti N, Feldstein LR, Alexander KA, Ferrari M, Shaman J, Drake JM, Porco T, Eisenberg JN, Del Valle SY, Lofgren E, Scarpino SV, Eisenberg MC, Gao D, Hyman JM, Eubank S, Longini IM Jr.. (2014). Ebola: mobility data. Science (New York, N.Y.), 346(6208)

Halloran ME, Longini IM Jr.. (2014). Emerging, evolving, and established infectious diseases and interventions. Science (New York, N.Y.), 345(6202)

Tran CH, Sugimoto JD, Pulliam JR, Ryan KA, Myers PD, Castleman JB, Doty R, Johnson J, Stringfellow J, Kovacevich N, Brew J, Cheung LL, Caron B, Lipori G, Harle CA, Alexander C, Yang Y, Longini IM Jr., Halloran ME, Morris JG Jr., Small PA Jr.. (2014). School-located influenza vaccination reduces community risk for influenza and influenza-like illness emergency care visits. PloS one, 9(12)

Gomes MF, Pastore Y Piontti A, Rossi L, Chao D, Longini I, Halloran ME, Vespignani A. (2014). Assessing the international spreading risk associated with the 2014 west african ebola outbreak. PLoS currents, (6)

Sugimoto JD, Koepke AA, Kenah EE, Halloran ME, Chowdhury F, Khan AI, LaRocque RC, Yang Y, Ryan ET, Qadri F, Calderwood SB, Harris JB, Longini IM Jr.. (2014). Household Transmission of Vibrio cholerae in Bangladesh. PLoS neglected tropical diseases, 8(11)

Dimitrov DT, Troeger C, Halloran ME, Longini IM, Chao DL. (2014). Comparative effectiveness of different strategies of oral cholera vaccination in bangladesh: a modeling study. PLoS neglected tropical diseases, 8(12)

Chao DL, Longini IM Jr., Halloran ME. (2013). The effects of vector movement and distribution in a mathematical model of dengue transmission. PLoS One, 8(10)

Matrajt L, Halloran ME, Longini IM Jr.. (2013). Optimal vaccine allocation for the early mitigation of pandemic influenza. PLoS computational biology, 9(3)

Chao DL, Halstead SB, Halloran ME, Longini IM Jr.. (2012). Controlling dengue with vaccines in Thailand. PLoS neglected tropical diseases, 6(10)

Yang Y, Longini IM Jr., Halloran ME, Obenchain V. (2012). A hybrid EM and Monte Carlo EM algorithm and its application to analysis of transmission of infectious diseases. Biometrics, 68(4)

Matrajt L, Longini IM Jr.. (2012). Critical immune and vaccination thresholds for determining multiple influenza epidemic waves. Epidemics, 4(1)

Potter GE, Handcock MS, Longini IM Jr., Halloran ME. (2012). ESTIMATING WITHIN-SCHOOL CONTACT NETWORKS TO UNDERSTAND INFLUENZA TRANSMISSION. The annals of applied statistics, 6(1)

Longini IM Jr.. (2012). A theoretic framework to consider the effect of immunizing schoolchildren against influenza: implications for research. Pediatrics, (129 Suppl 2)

Chao DL, Bloom JD, Kochin BF, Antia R, Longini IM Jr.. (2012). The global spread of drug-resistant influenza. Journal of the Royal Society, Interface, 9(69)

Chao DL, Matrajt L, Basta NE, Sugimoto JD, Dean B, Bagwell DA, Oiulfstad B, Halloran ME, Longini IM Jr.. (2011). Planning for the control of pandemic influenza A (H1N1) in Los Angeles County and the United States. American journal of epidemiology, 173(10)

Chao DL, Halloran ME, Longini IM Jr.. (2011). Vaccination strategies for epidemic cholera in Haiti with implications for the developing world. Proceedings of the National Academy of Sciences of the United States of America, 108(17)

Kenah E, Chao DL, Matrajt L, Halloran ME, Longini IM Jr.. (2011). The global transmission and control of influenza. PLoS One, 6(5)

Potter GE, Handcock MS, Longini IM Jr., Halloran ME. (2011). ESTIMATING WITHIN-HOUSEHOLD CONTACT NETWORKS FROM EGOCENTRIC DATA. The annals of applied statistics, 5(3)

Alsallaq RA, Schiffer JT, Longini IM Jr., Wald A, Corey L, Abu-Raddad LJ. (2010). Population level impact of an imperfect prophylactic vaccine for herpes simplex virus-2. Sexually transmitted diseases, 37(5)

Chao DL, Halloran ME, Obenchain VJ, Longini IM Jr.. (2010). FluTE, a publicly available stochastic influenza epidemic simulation model. PLoS computational biology, 6(1)

Chao DL, Halloran ME, Longini IM Jr.. (2010). School opening dates predict pandemic influenza A(H1N1) outbreaks in the United States. The Journal of infectious diseases, 202(6)

Matrajt L Jr., Longini IM. (2010). Optimizing vaccine allocation at different points in time during an epidemic. PLoS One, 5(11)

Van Kerkhove MD, Asikainen T, Becker NG, Bjorge S, Desenclos JC, dos Santos T, Fraser C, Leung GM, Lipsitch M, Longini IM Jr., McBryde ES, Roth CE, Shay DK, Smith DJ, Wallinga J, White PJ, Ferguson NM, Riley S, . (2010). Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling. PLoS medicine, 7(6)

Yang Y, Halloran ME, Daniels MJ, Longini IM Jr., Burke DS, Cummings DA. (2010). Modeling Competing Infectious Pathogens from a Bayesian Perspective: Application to Influenza Studies with Incomplete Laboratory Results. Journal of the American Statistical Association, 105(492)

Handel A, Longini IM Jr., Antia R. (2010). Towards a quantitative understanding of the within-host dynamics of influenza A infections. Journal of the Royal Society, Interface, 7(42)

Basta NE, Chao DL, Halloran ME, Matrajt L, Longini IM Jr.. (2009). Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States. American journal of epidemiology, 170(6)

Yang Y, Sugimoto JD, Halloran ME, Basta NE, Chao DL, Matrajt L, Potter G, Kenah E, Longini IM Jr.. (2009). The transmissibility and control of pandemic influenza A (H1N1) virus. Science (New York, N.Y.), 326(5953)

Abu-Raddad LJ, Sabatelli L, Achterberg JT, Sugimoto JD, Longini IM Jr., Dye C, Halloran ME. (2009). Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proceedings of the National Academy of Sciences of the United States of America, 106(33)

Yang Y, Halloran ME, Longini IM Jr.. (2009). A Bayesian model for evaluating influenza antiviral efficacy in household studies with asymptomatic infections. Biostatistics (Oxford, England), 10(2)

Cowling BJ, Ng S, Longini IM Jr.. (2009). A/H1N1 flu pandemic. Antiviral drugs: distinguish treatment from prophylaxis. BMJ (Clinical research ed.), (339)

Alsallaq RA, Cash B, Weiss HA, Longini IM Jr., Omer SB, Wawer MJ, Gray RH, Abu-Raddad LJ. (2009). Quantitative assessment of the role of male circumcision in HIV epidemiology at the population level. Epidemics, 1(3)

Handel A, Longini IM Jr., Antia R. (2009). Intervention strategies for an influenza pandemic taking into account secondary bacterial infections. Epidemics, 1(3)

Abu-Raddad LJ, Longini IM Jr.. (2008). No HIV stage is dominant in driving the HIV epidemic in sub-Saharan Africa. AIDS (London, England), 22(9)

Sander B, Nizam A, Garrison LP Jr., Postma MJ, Halloran ME, Longini IM Jr.. (2008). Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 12(2)

Handel A, Longini IM Jr., Antia R. (2009). Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details. Journal of theoretical biology, 256(1)

Halloran ME, Ferguson NM, Eubank S, Longini IM Jr., Cummings DA, Lewis B, Xu S, Fraser C, Vullikanti A, Germann TC, Wagener D, Beckman R, Kadau K, Barrett C, Macken CA, Burke DS, Cooley P. (2008). Modeling targeted layered containment of an influenza pandemic in the United States. Proceedings of the National Academy of Sciences of the United States of America, 105(12)

Basta NE, Halloran ME, Matrajt L, Longini IM Jr.. (2008). Estimating influenza vaccine efficacy from challenge and community-based study data. American journal of epidemiology, 168(12)

Yang Y, Gilbert P, Longini IM, Halloran ME. (2008). A Bayesian Framework for Estimating Vaccine Efficacy per Infectious Contact. The annals of applied statistics, 2(4)

Halloran ME, Piedra PA, Longini IM Jr., Gaglani MJ, Schmotzer B, Fewlass C, Herschler GB, Glezen WP. (2007). Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004. Vaccine, 25(20)

Longini IM Jr., Nizam A, Ali M, Yunus M, Shenvi N, Clemens JD. (2007). Controlling endemic cholera with oral vaccines. PLoS medicine, 4(11)

Handel A, Longini IM Jr., Antia R. (2007). What is the best control strategy for multiple infectious disease outbreaks?. Proceedings. Biological sciences, 274(1611)

Yang Y, Longini IM, Halloran ME. (2007). A Data-Augmentation Method for Infectious Disease Incidence Data from Close Contact Groups. Computational statistics & data analysis, 51(12)

Abu-Raddad LJ, Boily MC, Self S, Longini IM Jr.. (2007). Analytic insights into the population level impact of imperfect prophylactic HIV vaccines. Journal of acquired immune deficiency syndromes (1999), 45(4)

Handel A, Longini IM Jr., Antia R. (2007). Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread. PLoS computational biology, 3(12)

Yang Y, Halloran ME, Sugimoto JD, Longini IM Jr.. (2007). Detecting human-to-human transmission of avian influenza A (H5N1). Emerging infectious diseases, 13(9)

Yang Y, Longini IM, Halloran ME. (2007). A Resampling-Based Test to Detect Person-To-Person Transmission of Infectious Disease. The annals of applied statistics, 1(1)

Longini IM Jr., Halloran ME, Nizam A, Yang Y, Xu S, Burke DS, Cummings DA, Epstein JM. (2007). Containing a large bioterrorist smallpox attack: a computer simulation approach. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 11(2)

Halloran ME, Hayden FG, Yang Y, Longini IM Jr., Monto AS. (2007). Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. American journal of epidemiology, 165(2)

Halloran ME, Longini IM Jr.. (2006). Public health. Community studies for vaccinating schoolchildren against influenza. Science (New York, N.Y.), 311(5761)

Yang Y, Longini IM Jr., Halloran ME. (2006). Design and Evaluation of Prophylactic Interventions Using Infectious Disease Incidence Data from Close Contact Groups. Journal of the Royal Statistical Society. Series C, Applied statistics, 55(3)

Patel R, Longini IM Jr., Halloran ME. (2005). Finding optimal vaccination strategies for pandemic influenza using genetic algorithms. Journal of theoretical biology, 234(2)

Longini IM Jr., Halloran ME. (2005). Strategy for distribution of influenza vaccine to high-risk groups and children. American journal of epidemiology, 161(4)

Longini IM Jr., Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings DA, Halloran ME. (2005). Containing pandemic influenza at the source. Science (New York, N.Y.), 309(5737)

Longini IM Jr., Halloran ME, Nizam A, Yang Y. (2004). Containing pandemic influenza with antiviral agents. American journal of epidemiology, 159(7)

Glezen WP, Piedra PA, Longini IM, Halloran ME. (2004). Safety of cold-adapted live influenza vaccine. The Pediatric infectious disease journal, 23(6)

Halloran ME, Longini IM Jr., Gaglani MJ, Piedra PA, Chu H, Herschler GB, Glezen WP. (2003). Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures. American journal of epidemiology, 158(4)

Longini IM Jr., Yunus M, Zaman K, Siddique AK, Sack RB, Nizam A. (2002). Epidemic and endemic cholera trends over a 33-year period in Bangladesh. The Journal of infectious diseases, 186(2)

Halloran ME, Longini IM Jr., Nizam A, Yang Y. (2002). Containing bioterrorist smallpox. Science (New York, N.Y.), 298(5597)

Longini IM Jr., Halloran ME, Nizam A. (2002). Model-based estimation of vaccine effects from community vaccine trials. Statistics in medicine, 21(4)

Hill AN, Longini IM Jr.. (2003). The critical vaccination fraction for heterogeneous epidemic models. Mathematical biosciences, 181(1)

Halloran ME, Longini IM, Cowart DM, Nizam A. (2002). Community interventions and the epidemic prevention potential. Vaccine, 20(27-28)

Halloran ME, Longini IM Jr.. (2001). Using validation sets for outcomes and exposure to infection in vaccine field studies. American journal of epidemiology, 154(5)

Halloran ME, Longini IM Jr., Struchiner CJ. (1999). Design and interpretation of vaccine field studies. Epidemiologic reviews, 21(1)

Longini IM Jr., Sagatelian K, Rida WN, Halloran ME. (1998). Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations. Statistics in medicine, 17(10)

Halloran ME, Struchiner CJ, Longini IM Jr.. (1997). Study designs for evaluating different efficacy and effectiveness aspects of vaccines. American journal of epidemiology, 146(10)

Longini IM Jr., Datta S, Halloran ME. (1996). Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccines. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 13(5)

Halloran ME, Longini IM Jr., Struchiner CJ. (1996). Estimability and interpretation of vaccine efficacy using frailty mixing models. American journal of epidemiology, 144(1)

Longini IM Jr., Halloran ME. (1995). AIDS: modeling epidemic control. Science (New York, N.Y.), 267(5202)

Halloran ME, Longini IM Jr., Haber MJ, Struchiner CJ, Brunet RC. (1994). Exposure efficacy and change in contact rates in evaluating prophylactic HIV vaccines in the field. Statistics in medicine, 13(4)

Halloran ME, Haber M, Longini IM Jr.. (1992). Interpretation and estimation of vaccine efficacy under heterogeneity. American journal of epidemiology, 136(3)

Halloran ME, Haber M, Longini IM Jr., Struchiner CJ. (1991). Direct and indirect effects in vaccine efficacy and effectiveness. American journal of epidemiology, 133(4)

Haber M, Longini IM Jr., Halloran ME. (1991). Measures of the effects of vaccination in a randomly mixing population. International journal of epidemiology, 20(1)

Haber M, Longini IM Jr., Halloran ME. (1991). Estimation of vaccine efficacy in outbreaks of acute infectious diseases. Statistics in medicine, 10(10)

Longini IM Jr., Haber MJ, Halloran ME. (1990). [Direct and indirect effects of vaccines: an annotation on the estimation of the vaccine efficacy from outbreaks caused by acute infection agents such as measles]. Boletin medico del Hospital Infantil de Mexico, 47(7)

If you’d like to update your profile, please email modifications to questions@midasnetwork.us.